Title |
Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study
|
---|---|
Published in |
European Journal of Preventive Cardiology, July 2016
|
DOI | 10.1177/2047487316651982 |
Pubmed ID | |
Authors |
Maria Cristina Penaloza-Ramos, Sue Jowett, Pelham Barton, Andrea Roalfe, Kate Fletcher, Clare J Taylor, FD Richard Hobbs, Richard J McManus, Jonathan Mant |
Abstract |
The PAST-BP trial found that using a lower systolic blood pressure target (<130 mmHg or lower versus <140 mmHg) in a primary care population with prevalent cerebrovascular disease was associated with a small additional reduction in blood pressure (2.9 mmHg). To determine the cost effectiveness of an intensive systolic blood pressure target (<130 mmHg or lower) compared with a standard target (<140 mmHg) in people with a history of stroke or transient ischaemic attack on general practice stroke/transient ischaemic attack registers in England. A Markov model with a one-year time cycle and a 30-year time horizon was used to estimate the cost per quality-adjusted life year of an intensive target versus a standard target. Individual patient level data were used from the PAST-BP trial with regard to change in blood pressure and numbers of primary care consultations over a 12-month period. Published sources were used to estimate life expectancy and risks of cardiovascular events and their associated costs and utilities. In the base-case results, aiming for an intensive blood pressure target was dominant, with the incremental lifetime costs being £169 lower per patient than for the standard blood pressure target with a 0.08 quality-adjusted life year gain. This was robust to sensitivity analyses, unless intensive blood pressure lowering reduced quality of life by 2% or more. Aiming for a systolic blood pressure target of <130 mmHg or lower is cost effective in people who have had a stroke/transient ischaemic attack in the community, but it is difficult to separate out the impact of the lower target from the impact of more active management of blood pressure. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 63% |
Australia | 1 | 13% |
Unknown | 2 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Scientists | 3 | 38% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 1% |
Unknown | 87 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 15% |
Researcher | 11 | 13% |
Student > Master | 9 | 10% |
Student > Doctoral Student | 8 | 9% |
Student > Ph. D. Student | 7 | 8% |
Other | 14 | 16% |
Unknown | 26 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 23% |
Nursing and Health Professions | 9 | 10% |
Unspecified | 5 | 6% |
Neuroscience | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 18 | 20% |
Unknown | 30 | 34% |